Current state-of-the-art therapy for advanced squamous cell lung cancer

American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting

Volumn , Issue , 2013, Pages 354-358

  Scagliotti, Giorgio V ^a   Novello, Silvia ^a   Rapetti, Simonetta ^a   Papotti, Mauro ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; TUMOR MARKER; TUMOR PROTEIN;

CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CLASSIFICATION; CLINICAL TRIAL (TOPIC); GENETICS; HUMAN; LUNG NEOPLASMS; MUTATION; PATHOLOGY; SALVAGE THERAPY; TREATMENT OUTCOME; TUMOR GENE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOMARKERS, TUMOR; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CLINICAL TRIALS AS TOPIC; GENES, NEOPLASM; HUMANS; LUNG NEOPLASMS; MUTATION; NEOPLASM PROTEINS; SALVAGE THERAPY; TREATMENT OUTCOME;

EID: 84938204294     PISSN: None     EISSN: 15488756     Source Type: Journal    
DOI: 10.1200/EdBook_AM.2013.33.354     Document Type: Review

References (0)